Navigation Links
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infection
Date:4/22/2013

107 x 14d

All VP20621 dosesn

43

41

43

41

125NTCD detected in stool during

14 day administration period

0%

54%

79%

73%

69%p value vs. placebo<0.0001

<0.0001

<0.0001

<0.0001CDI Recurrence

30%

15%

5%

15%

11%p value vs. placebo0.11

<0.01

0.10

<0.01 Antibacterial Use for CDI

Treatment

33%

15%

9%

17%

14%p value vs. placebo0.06

0.02

0.14

<0.01 Event of diarrhea or loose stool

of any severity or duration

77%

56%

58%

56%

57%p value vs. placebo0.05

0.09

0.02

0.02Safety:VP20621 exhibited a favorable tolerability profile:

  • There were no notable differences in adverse events between the different VP20621 dose groups;
  • Overall, treatment-emergent adverse events were reported in 86 percent of placebo subjects and 78 percent of all VP20621 subjects;
  • Treatment-emergent serious adverse events were reported in 7 percent and 3 percent of placebo and VP20621 subjects, respectively, though none were considered related to study drug;
  • Diarrhea events are shown in the table above. Abdominal pain was reported in 33 percent of placebo subjects and 17 percent of all VP20621 subjects;
  • The only adverse event with apparent association with VP20621 was headache: Two percent for placebo subjects vs. 10 percent for all VP20621 subjects;
  • There were 2 deaths:
  • One subject in the placebo group had severe recurrent CDI that did not respond to attempted fecal transplant; death was attributed to the CDI and subsequent respiratory failure;
  • One subject in the VP20621 high-dose (14 day) group was diagnosed with recurrent CDI and fell a
    '/>"/>

  • SOURCE ViroPharma Incorporated
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
    3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
    4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
    5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
    6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
    7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
    8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
    9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
    10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
    11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
    (Date:7/31/2014)... and VIENNA , July 31, ... a press conference in New York ... a vaccine against Parkinson,s disease. PD01A is the first therapy ... enter clinical testing. The Michael J. Fox Foundation ... 1.5 million grant, and presented at the press conference on ...
    (Date:7/31/2014)... and LONDON , July 31, 2014 ... provider for the medical industries, announced today the incorporation of genae ... United Kingdom has one of the largest medical ... billion in 2012 and it is projected to increase by a ... 234 billion in 2012, equal to 9.5% of GDP. Despite recessionary ...
    Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4genae Opens Offices in London 2
    ... NEW YORK, April 14, 2011 Reportlinker.com announces ... in its catalogue: Macular Degeneration ... http://www.reportlinker.com/p0472337/Macular-Degeneration-Therapy-Area-Pipeline-Report.html The Macular Degeneration Therapy ... macular degeneration drug pipeline. This report provides insight ...
    ... April 13, 2011 RushCard announced today that money-saving ... members.  The plans allow for savings on a variety ... diabetes management products, lab services and more. ... health care offerings, bringing unmatched value to RushCard members. ...
    Cached Medicine Technology:Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 2Reportlinker Adds Macular Degeneration Therapy Area Pipeline Report 3RushCard Offers Members Exclusive Discounts on Health Care Services 2
    (Date:7/31/2014)... Miami, FL (PRWEB) July 31, 2014 ... recently released their innovative compression elbow sleeve , ... other elbow pain, in two new bright colors for ... neon pink and blue. Made of innovative proprietary Zensah® ... moisture wicking and odor-preventing fabric. It features a no-slip ...
    (Date:7/31/2014)... New York (PRWEB) July 31, 2014 ... whistleblowers in qui tam cases, comments that whistleblowers are ... end to illegal employer activities that may cause harm ... that today is National Whistleblower Appreciation Day. , According ... Whistleblower Center , the Senate declared "National Whistleblower Appreciation ...
    (Date:7/31/2014)... 31, 2014 CarePoint Health is ... Masood Rizvi, has joined our network, CarePoint Health ... the community. Hundreds of highly skilled and experienced ... network of top doctors and practices in Hudson ... latest acquisition represents CarePoint Health’s commitment to provide ...
    (Date:7/31/2014)... July 31, 2014 You’re having a wonderful ... have you suddenly developed chills and fever, headache, stiff neck, ... suspect a flu-like illness, it could actually be the first ... risk of developing Lyme is greater than you might think. ... cases occurred in the U.S. annually. But the Centers for ...
    (Date:7/31/2014)... 2014 Two years in the making, ... overview of the research behind the latest scientific findings ... and Vesanto Melina, well-respected authorities on plant-based nutrition, put ... safe and adequate for people at all stages of ... athletes and pregnant or lactating women. , Well-planned ...
    Breaking Medicine News(10 mins):Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 2Health News:Compression Elbow Sleeve Provides Relief From Elbow Pain to Golfers and Tennis Players 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 2Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 3Health News:National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments 4Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3
    ... 30 The misleading "health" halo surrounding highly-publicized marketing ... , Recent announcements by Starbucks and other brands ... certain products are being called into question in news ... articles have poked holes in companies, marketing efforts and ...
    ... S.C., June 30 Informatics Corporation of America (ICA) ... (CDS) to offer a solution that integrates with and ... electronic health record. ICA and CDS will offer health ... move clinical information among disparate health care information systems ...
    ... success, welcoming 1012 visitors who left the show impressed and vowing ... A total success. That sums up ... held for the first time on June 15-16, 2009 at Sao ... over 1000 key decision-makers in the food industry, in this, its ...
    ... Facilities in Pennsylvania Make Substantial Progress in Reducing Infections ... Pa., June 30 Two hospitals in southeast Pennsylvania ... intensive care patients in their facilities and are featured ... Safety Advisory. , , Patients in intensive ...
    ... Fla., June 30 JAG Media Holdings, Inc. (OTC Bulletin ... of its acquisition of CardioGenics Inc. by its Ontario, Canada ... currently scheduled for June 30, 2009, has been rescheduled to ... the parties sufficient time to attend to the remaining closing ...
    ... The Netherlands: Women who have a diminished number of eggs ... some other reason such as ovarian surgery, may be more ... ovarian reserve within the normal, fertile range. Trisomic pregnancies ... rather than the normal two. The most common trisomy is ...
    Cached Medicine News:Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 2Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 3Health News:ICA, CDS Team Up to Offer Solution That Aggregates Patient Information 2Health News:ICA, CDS Team Up to Offer Solution That Aggregates Patient Information 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 2Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 2Health News:Pennsylvania Patient Safety Authority Releases June Advisory 3Health News:Pennsylvania Patient Safety Authority Releases June Advisory 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 5Health News:JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. 2Health News:JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. 3Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3
    ... Bottled Water, The Simplicity personal water system ... currently use bottled water. In addition to ... store bottled water, your laboratory applications may ... be absorbed from containers and cause water ...
    ... to 12 L/min of Type I ultrapure ... The Super-Q Plus System is designed to ... has been pretreated by reverse osmosis, distillation ... ultrapure water quality which exceeds Type I ...
    ... System Produces Type I Water Directly from Tap, ... for scientists who need 5 to 15 L ... have easy access to acceptable quality pretreated water. ... L/min of ultrapure (Type I) water on demand, ...
    TOPLOAD 3200/0.01G, BL3200H. Touch-key external calibration only. Requires calibration weights (either 2000g or 3000g). 120/240V A/C adapter, Lock-down Ring, In-use Protective Cover....
    Medicine Products: